Do analysts recommend SLSN or WALD?

Waldencast has a consensus target price of $2.33, suggesting a potential upside of 101.15%. Given Waldencast's stronger consensus rating and higher possible upside, analysts clearly believe Waldencast is more favorable than Solesence. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solesence 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Waldencast 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has stronger valuation and earnings, SLSN or WALD?

Solesence has higher earnings, but lower revenue than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Solesence $62.06M 0.91 $1.79M -$0.03 N/A Waldencast $272.07M 0.55 -$229.75M N/A N/A

Do analysts rate MED or SLSN?

Medifast currently has a consensus price target of $12.00, suggesting a potential upside of 1.76%. Given Medifast's stronger consensus rating and higher probable upside, analysts plainly believe Medifast is more favorable than Solesence. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medifast 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Solesence 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is MED or SLSN more profitable?

Solesence has a net margin of -3.40% compared to Medifast's net margin of -8.08%. Medifast's return on equity of -6.69% beat Solesence's return on equity. Company Net Margins Return on Equity Return on Assets Medifast -8.08% -6.69% -5.25% Solesence -3.40% -11.58% -3.79%

Do analysts prefer SLSN or SKIN?

Beauty Health has a consensus price target of $1.38, indicating a potential upside of 103.70%. Given Beauty Health's stronger consensus rating and higher probable upside, analysts clearly believe Beauty Health is more favorable than Solesence. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solesence 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Beauty Health 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate FTLF or SLSN?

FitLife Brands presently has a consensus target price of $18.00, indicating a potential upside of 93.13%. Given FitLife Brands' stronger consensus rating and higher possible upside, equities research analysts clearly believe FitLife Brands is more favorable than Solesence. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FitLife Brands 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Solesence 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend LFVN or SLSN?

Lifevantage currently has a consensus price target of $5.50, suggesting a potential downside of 13.39%. Given Lifevantage's stronger consensus rating and higher probable upside, analysts plainly believe Lifevantage is more favorable than Solesence. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifevantage 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Solesence 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, LFVN or SLSN?

Lifevantage has higher revenue and earnings than Solesence. Solesence is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lifevantage $182.59M 0.44 $5.07M $0.40 15.88 Solesence $62.06M 0.91 $1.79M -$0.03 N/A

Is LFVN or SLSN more profitable?

Lifevantage has a net margin of 2.78% compared to Solesence's net margin of -3.40%. Lifevantage's return on equity of 21.56% beat Solesence's return on equity. Company Net Margins Return on Equity Return on Assets Lifevantage 2.78% 21.56% 11.62% Solesence -3.40% -11.58% -3.79%

Solesence (SLSN) Competitors

$0.80 -0.02 (-2.35%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.82 +0.02 (+2.66%)

As of 09/18/2026 07:58 PM Eastern

Compare

SLSN vs. WALD, MED, SKIN, FTLF, and LFVN

Should you buy Solesence stock or one of its competitors? Solesence's main competitors and comparable companies include Waldencast (WALD), Medifast (MED), Beauty Health (SKIN), FitLife Brands (FTLF), and Lifevantage (LFVN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Solesence compare to Waldencast?

Solesence (NASDAQ:SLSN) and Waldencast (NASDAQ:WALD) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

Waldencast has a net margin of 0.00% compared to Solesence's net margin of -3.40%. Waldencast's return on equity of 0.00% beat Solesence's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solesence	-3.40%	-11.58%	-3.79%
Waldencast	N/A	N/A	N/A

Solesence has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market. Comparatively, Waldencast has a beta of -0.15, meaning that its share price is 115% less volatile than the broader market.

70.2% of Solesence shares are owned by institutional investors. Comparatively, 42.0% of Waldencast shares are owned by institutional investors. 4.8% of Solesence shares are owned by company insiders. Comparatively, 5.9% of Waldencast shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Solesence has higher earnings, but lower revenue than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solesence	$62.06M	0.91	$1.79M	-$0.03	N/A
Waldencast	$272.07M	0.55	-$229.75M	N/A	N/A

Waldencast has a consensus target price of $2.33, suggesting a potential upside of 101.15%. Given Waldencast's stronger consensus rating and higher possible upside, analysts clearly believe Waldencast is more favorable than Solesence.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solesence	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Waldencast had 2 more articles in the media than Solesence. MarketBeat recorded 2 mentions for Waldencast and 0 mentions for Solesence. Solesence's average media sentiment score of 0.00 equaled Waldencast'saverage media sentiment score.

Company	Overall Sentiment
Solesence	Neutral
Waldencast	Neutral

Summary

Waldencast beats Solesence on 9 of the 13 factors compared between the two stocks.

How does Solesence compare to Medifast?

Medifast (NYSE:MED) and Solesence (NASDAQ:SLSN) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, Medifast had 2 more articles in the media than Solesence. MarketBeat recorded 2 mentions for Medifast and 0 mentions for Solesence. Medifast's average media sentiment score of 0.34 beat Solesence's score of 0.00 indicating that Medifast is being referred to more favorably in the media.

Company	Overall Sentiment
Medifast	Neutral
Solesence	Neutral

Medifast currently has a consensus price target of $12.00, suggesting a potential upside of 1.76%. Given Medifast's stronger consensus rating and higher probable upside, analysts plainly believe Medifast is more favorable than Solesence.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medifast	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Solesence	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Medifast has a beta of 0.71, indicating that its stock price is 29% less volatile than the broader market. Comparatively, Solesence has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

Solesence has lower revenue, but higher earnings than Medifast. Solesence is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medifast	$385.79M	0.34	-$18.67M	-$2.33	N/A
Solesence	$62.06M	0.91	$1.79M	-$0.03	N/A

95.5% of Medifast shares are owned by institutional investors. Comparatively, 70.2% of Solesence shares are owned by institutional investors. 3.7% of Medifast shares are owned by company insiders. Comparatively, 4.8% of Solesence shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Solesence has a net margin of -3.40% compared to Medifast's net margin of -8.08%. Medifast's return on equity of -6.69% beat Solesence's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medifast	-8.08%	-6.69%	-5.25%
Solesence	-3.40%	-11.58%	-3.79%

Summary

Medifast beats Solesence on 8 of the 15 factors compared between the two stocks.

How does Solesence compare to Beauty Health?

Solesence (NASDAQ:SLSN) and Beauty Health (NASDAQ:SKIN) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

70.2% of Solesence shares are owned by institutional investors. Comparatively, 93.3% of Beauty Health shares are owned by institutional investors. 4.8% of Solesence shares are owned by company insiders. Comparatively, 35.5% of Beauty Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Solesence has a net margin of -3.40% compared to Beauty Health's net margin of -9.79%. Solesence's return on equity of -11.58% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solesence	-3.40%	-11.58%	-3.79%
Beauty Health	-9.79%	-47.83%	-5.79%

Beauty Health has a consensus price target of $1.38, indicating a potential upside of 103.70%. Given Beauty Health's stronger consensus rating and higher probable upside, analysts clearly believe Beauty Health is more favorable than Solesence.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solesence	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Beauty Health	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Beauty Health had 4 more articles in the media than Solesence. MarketBeat recorded 4 mentions for Beauty Health and 0 mentions for Solesence. Beauty Health's average media sentiment score of 0.84 beat Solesence's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Solesence	Neutral
Beauty Health	Positive

Solesence has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Beauty Health has a beta of 1, indicating that its share price has a similar volatility profile to the broader market.

Solesence has higher earnings, but lower revenue than Beauty Health. Solesence is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solesence	$62.06M	0.91	$1.79M	-$0.03	N/A
Beauty Health	$300.80M	0.29	-$9.52M	-$0.22	N/A

Summary

Beauty Health beats Solesence on 9 of the 16 factors compared between the two stocks.

How does Solesence compare to FitLife Brands?

FitLife Brands (NASDAQ:FTLF) and Solesence (NASDAQ:SLSN) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

FitLife Brands has a net margin of 6.15% compared to Solesence's net margin of -3.40%. FitLife Brands' return on equity of 18.10% beat Solesence's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	6.15%	18.10%	7.63%
Solesence	-3.40%	-11.58%	-3.79%

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 70.2% of Solesence shares are held by institutional investors. 61.7% of FitLife Brands shares are held by insiders. Comparatively, 4.8% of Solesence shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, FitLife Brands' average media sentiment score of 0.80 beat Solesence's score of 0.00 indicating that FitLife Brands is being referred to more favorably in the media.

Company	Overall Sentiment
FitLife Brands	Positive
Solesence	Neutral

FitLife Brands has higher revenue and earnings than Solesence. Solesence is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$81.46M	1.07	$6.33M	$0.62	15.03
Solesence	$62.06M	0.91	$1.79M	-$0.03	N/A

FitLife Brands presently has a consensus target price of $18.00, indicating a potential upside of 93.13%. Given FitLife Brands' stronger consensus rating and higher possible upside, equities research analysts clearly believe FitLife Brands is more favorable than Solesence.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Solesence	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

FitLife Brands beats Solesence on 13 of the 14 factors compared between the two stocks.

How does Solesence compare to Lifevantage?

Lifevantage (NASDAQ:LFVN) and Solesence (NASDAQ:SLSN) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

35.3% of Lifevantage shares are held by institutional investors. Comparatively, 70.2% of Solesence shares are held by institutional investors. 22.0% of Lifevantage shares are held by insiders. Comparatively, 4.8% of Solesence shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Lifevantage has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Solesence has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market.

Lifevantage has higher revenue and earnings than Solesence. Solesence is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifevantage	$182.59M	0.44	$5.07M	$0.40	15.88
Solesence	$62.06M	0.91	$1.79M	-$0.03	N/A

Lifevantage has a net margin of 2.78% compared to Solesence's net margin of -3.40%. Lifevantage's return on equity of 21.56% beat Solesence's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifevantage	2.78%	21.56%	11.62%
Solesence	-3.40%	-11.58%	-3.79%

In the previous week, Lifevantage had 6 more articles in the media than Solesence. MarketBeat recorded 6 mentions for Lifevantage and 0 mentions for Solesence. Lifevantage's average media sentiment score of 0.21 beat Solesence's score of 0.00 indicating that Lifevantage is being referred to more favorably in the media.

Company	Overall Sentiment
Lifevantage	Neutral
Solesence	Neutral

Lifevantage currently has a consensus price target of $5.50, suggesting a potential downside of 13.39%. Given Lifevantage's stronger consensus rating and higher probable upside, analysts plainly believe Lifevantage is more favorable than Solesence.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifevantage	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Solesence	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Lifevantage beats Solesence on 12 of the 15 factors compared between the two stocks.

Get Solesence News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLSN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SLSN vs. The Competition

Export

Metric	Solesence	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$58.13M	$22.99B	$15.67B	$13.14B
Dividend Yield	N/A	4.64%	3.23%	12.30%
P/E Ratio	-26.79	20.08	14.18	25.40
Price / Sales	0.91	12.66	262,949.00	114.47
Price / Cash	21.60	26.83	56.69	51.66
Price / Book	3.21	2.88	4.69	6.33
Net Income	$1.79M	$1.13B	$836.60M	$358.33M
7 Day Performance	-0.62%	-2.39%	-0.95%	1.12%
1 Month Performance	-14.56%	-2.92%	-2.96%	-2.67%
1 Year Performance	-76.77%	-14.84%	10.36%	6.01%

Solesence Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SLSN Solesence	0.1285 of 5 stars	$0.80 -2.3%	N/A	-76.6%	$58.13M	$62.06M	N/A	115
WALD Waldencast	2.2818 of 5 stars	$1.31 -1.5%	$2.33 +78.1%	-44.2%	$168.47M	$272.07M	N/A	272	Positive News Gap Up
MED Medifast	1.1221 of 5 stars	$12.04 -0.1%	$12.00 -0.3%	-19.1%	$134.62M	$316.93M	N/A	870
SKIN Beauty Health	1.9765 of 5 stars	$0.70 +1.4%	$1.38 +96.4%	-71.5%	$89.80M	$290.05M	N/A	1,030	Gap Down
FTLF FitLife Brands	4.3501 of 5 stars	$9.21 -0.1%	$18.00 +95.4%	-51.3%	$86.59M	$101.27M	14.76	20	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SLSN) was last updated on 9/19/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Solesence (SLSN) Competitors

SLSN vs. WALD, MED, SKIN, FTLF, and LFVN

How does Solesence compare to Waldencast?

Summary

How does Solesence compare to Medifast?

Summary

How does Solesence compare to Beauty Health?

Summary

How does Solesence compare to FitLife Brands?

Summary

How does Solesence compare to Lifevantage?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLSN vs. The Competition

Solesence Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Solesence (SLSN) Competitors

SLSN vs. WALD, MED, SKIN, FTLF, and LFVN

How does Solesence compare to Waldencast?

Is SLSN or WALD more profitable?

Which has more risk and volatility, SLSN or WALD?

Do insiders and institutionals hold more shares of SLSN or WALD?

Which has stronger valuation and earnings, SLSN or WALD?

Do analysts recommend SLSN or WALD?

Does the media prefer SLSN or WALD?

Summary

How does Solesence compare to Medifast?

Does the media favor MED or SLSN?

Do analysts rate MED or SLSN?

Which has more volatility and risk, MED or SLSN?

Which has better valuation and earnings, MED or SLSN?

Do insiders and institutionals hold more shares of MED or SLSN?

Is MED or SLSN more profitable?

Summary

How does Solesence compare to Beauty Health?

Do insiders & institutionals have more ownership in SLSN or SKIN?

Is SLSN or SKIN more profitable?

Do analysts prefer SLSN or SKIN?

Does the media refer more to SLSN or SKIN?

Which has more volatility and risk, SLSN or SKIN?

Which has preferable valuation & earnings, SLSN or SKIN?

Summary

How does Solesence compare to FitLife Brands?

Is FTLF or SLSN more profitable?

Do insiders and institutionals believe in FTLF or SLSN?

Does the media prefer FTLF or SLSN?

Which has preferable valuation and earnings, FTLF or SLSN?

Do analysts rate FTLF or SLSN?

Summary

How does Solesence compare to Lifevantage?

Do institutionals and insiders have more ownership in LFVN or SLSN?

Which has more volatility & risk, LFVN or SLSN?

Which has preferable earnings and valuation, LFVN or SLSN?

Is LFVN or SLSN more profitable?

Does the media favor LFVN or SLSN?

Do analysts recommend LFVN or SLSN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLSN vs. The Competition

Solesence Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools